With organic revenue this financial year expected to be around $280mil and the loan book growing over 25% per annum that means 2024 organic revenue will be around $350mil plus $20mil each for the NZ and UK acquisitions. So just short of $400mil for 2024 with corresponding growth in profits.
This is a great growth story and yet the SP is languishing. The overhang of unwanted shares is killing this stock.
Ann: Q3 FY 2023 Unaudited Trading Update, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $138.0M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.8¢ | 22.0¢ | $22.85K | 101.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 485394 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 3211 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| CCV (ASX) Chart |